Pharsight

Drugs that contain Ethinyl Estradiol; Norethindrone Acetate

1. Lo Loestrin Fe patents expiration

LO LOESTRIN FE Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7704984 APIL Extended estrogen dosing contraceptive regimen
Feb, 2029

(4 years from now)

Market Authorisation Date: 21 October, 2010

Treatment: Lo loestrin fe is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception

Dosage: TABLET;ORAL

How can I launch a generic of LO LOESTRIN FE before it's drug patent expiration?
More Information on Dosage

LO LOESTRIN FE family patents

Family Patents

2. Lo Minastrin Fe patents expiration

LO MINASTRIN FE Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7704984 APIL Extended estrogen dosing contraceptive regimen
Feb, 2029

(4 years from now)

Market Authorisation Date: 24 July, 2013

Treatment: Prevention of pregnancy

Dosage: TABLET, CHEWABLE, TABLET;ORAL

More Information on Dosage

LO MINASTRIN FE family patents

Family Patents